Endo International Plc
(NASDAQ : ENDP)

( )
ENDP After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
-0.27%169.660.4%$318.11m
AMRNAmarin Corporation Plc Sponsored ADR
-0.66%16.572.0%$239.83m
JAZZJazz Pharmaceuticals Plc
0.52%140.382.2%$115.51m
PRGOPerrigo Co. Plc
-0.59%58.506.8%$76.64m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.17%122.996.3%$57.96m
MNKMallinckrodt Plc
1.31%20.9521.1%$57.42m
ICLRICON Plc
-0.60%138.224.1%$45.74m
SAGESAGE Therapeutics, Inc.
0.27%107.849.6%$41.83m
UTHRUnited Therapeutics Corporation
1.19%109.7914.4%$40.53m
ENDPEndo International Plc
-1.23%11.218.9%$40.43m
ICPTIntercept Pharmaceuticals, Inc.
-1.32%104.5918.6%$39.92m
HZNPHorizon Pharma plc
0.00%19.567.4%$37.97m
CTLTCatalent Inc
1.67%36.302.4%$36.79m
ZGNXZogenix, Inc.
1.32%43.6510.0%$25.85m
AERIAerie Pharmaceuticals, Inc.
1.20%40.536.9%$25.36m

Company Profile

Endo International Plc operates as a pharmaceutical company. It focuses on developing, manufacturing, and distributing of branded and generic pharmaceutical products. The company operates through the following segments: U.S. Branded Pharmaceuticals, U.S. Generic pharmaceuticals and International Pharmaceuticals. The U.S. Branded Pharmaceuticals offers products that focus on the treatment and management of conditions in urology, urologic oncology, endocrinology, and orthopedics. The U.S. Generic pharmaceuticals segment consist of a differentiated product portfolio including high-barrier-to-entry products, first-to-file or first-to-market opportunities that are difficult to formulate, difficult to manufacture or face complex legal and regulatory challenges. The International Pharmaceuticals segment includes a variety of pharmaceutical products for the Canadian, Latin American, South African, and world markets. Endo International was founded in 1997 and is headquartered Dublin, Ireland.